Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, May 22, 2012
Technology Networks
 
Register | Sign in
Home Page
  Permissions

Permission to use, copy and distribute documents presented on this World Wide Web site and related graphics is not granted without prior written permission of Technology Networks Ltd

To obtain this permission contact:
Technology Networks Ltd
Unit 6, Woodview
Bull Lane
Acton
Sudbury
CO10 0FD, U.K.

In cases where permission is granted, it is done so under the provision that the above copyright notice and this permission notice appear in all copies. All other rights are reserved.

The information and data included in the TechnologyNetworks.com WWW site, and all its affiliated websites and associated email newsletters, have been compiled from a variety of sources, and are subject to change without notice. Technology Networks Ltd. makes no warranties or representations whatsoever regarding the quality, content, completeness, or adequacy of this information and data.

Technology Networks Ltd. specifically disclaims all warranties with respect to this WWW site, email newsletters or your use thereof, express, implied, or otherwise, including without limitation, all warranties of merchantability and fitness for a particular purpose. Technology Networks Ltd shall not be liable for any special, incidental, or consequential damages, including, without limitation, lost revenues, lost profits, or loss of prospective economic advantage, resulting from the use or misuse of this site, or the information therein.

Scientific News
New Technique Reveals Unseen Information in DNA Code
Scientists have developed and tested a technique to distinguish between two modified forms of cytosine.
World's First Approved Stem Cell Drug
Osiris Receives Marketing Clearance from Health Canada for Prochymal. Historic decision offers hope to children suffering from life-threatening GvHD.
Genetic Packing: Successful Stem Cell Differentiation Requires DNA Compaction, Study Finds
New research findings show that embryonic stem cells unable to fully compact the DNA inside them cannot complete their primary task: differentiation into specific cell types that give rise to the various types of tissues and structures in the body.
Promethera Biosciences Treats First Patients with Promethera® HepaStem
Phase I/II study designed to evaluate the ability of liver progenitor cells to restore a missing enzyme function in liver-based metabolic diseases.
New Muscular Dystrophy Treatment Approach Developed Using Human Stem Cells
New process makes the production of human muscle cells from stem cells efficient and effective.
Duke Team Turns Scar Tissue into Heart Muscle Without Using Stem Cells
Scientists at Duke University Medical Center have shown the ability to turn scar tissue that forms after a heart attack into heart muscle cells using a new process that eliminates the need for stem cell transplant.
“Housekeeping” Mechanism for Brain Stem Cells Discovered
Researchers at Columbia University Medical Center (CUMC) have identified a molecular pathway that controls the retention and release of the brain’s stem cells.
IBN Discovers Human Neural Stem Cells with Tumor Targeting Ability
The discovery is promising for the future of breast cancer therapy.
Researchers Derive Purified Lung and Thyroid Progenitors from Embryonic Stem Cells
Research provides information about tissue engineering technology which can be used to develop new gene and cell-based therapies to treat lung diseases.
Oxygen Levels Do Not Determine Radiation Survival of Breast Cancer Stem Cells
Today, oxygen is recognized to be one of the most powerful radiation sensitizers. This study outlines research into how breast cancer stem cells are protected from radiation through expression of free radical scavengers, with little increase provided by hypoxia.

Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net